FDA
-
-
-
-
-
-
-
Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Gain Therapeutics (GANX)
-
-
-
-
-
-
-
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
-
-
-
-
-
-
-
Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week
-
-
-
-
-
-
-
Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update
-
-
-
-
-
-
-
Gain Therapeutics starts extension study for Parkinson's drug GT-02287
-
-
-
-
-
-
-
Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


